Altana Pharma AG
Records under this name other than patents Altana Pharma AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,842,820 | Sulfonylpyrroles Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,371,292 | Use of Ciclesonide for the Treatment of Respiratory Diseases Formerly held In force · High confidence | In force | High confidence | |
| US 8,435,497 | Formoterol and Ciclesonide Combination Formerly held In force · High confidence | In force | High confidence | |
| US 9,422,327 | Process for preparing crystalline ciclesonide with defined particle size Formerly held In force · High confidence | In force | High confidence | |
| US 8,003,798 | Novel HYDROXY-6-Heteroarylphenanthridines and Their Use as PDE4 Inhibitors Formerly held Term ended Term ended Jul 9, 2026 · High confidence | Term ended | Term ended Jul 9, 2026 | High confidence |
| US 7,879,832 | Use of the Combination of Ciclesonide and Antihistamines for the Treatment of Allergic Rhinitis Formerly held Term ended Term ended Dec 4, 2025 · High confidence | Term ended | Term ended Dec 4, 2025 | High confidence |
| US 7,470,791 | Novel Process for the Preparation of Roflumilast Formerly held Term ended Term ended Oct 18, 2025 · High confidence | Term ended | Term ended Oct 18, 2025 | High confidence |
| US 7,776,893 | Use of PDE4 Inhibitors for the Treatment of Diabetes Mellitus Formerly held Term ended Term ended Jul 10, 2025 · High confidence | Term ended | Term ended Jul 10, 2025 | High confidence |
| US 8,464,707 | Compliance monitor and method Formerly held Lapsed on the fee record Ended Jun 18, 2025 · High confidence | Lapsed on the fee record | Ended Jun 18, 2025 | High confidence |
| US 7,879,833 | Combination Medicament Formerly held Term ended Term ended May 1, 2025 · High confidence | Term ended | Term ended May 1, 2025 | High confidence |